profit from every $100 of sales.
$0$100
Nexalin Technology
$1.59+8.16% today
-95.7% in 1 year
1-year low $1.401-year high $37.80
Trading close to its lowest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
It holds more cash than debt.
No debt5 years
Money in, money out
What Nexalin Technology sold, what it kept, and what it did with the cash.
Sales went from $1.32 million in 2022 to $301,647 in 2025, with -$8.22 million of profit last year.
SalesProfit
Nexalin Technology vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Nexalin Technology | No profit yet | ||
 Boston Scientific | 22.6× · Fair price | ||
 Koninklijke Philips | 29.7× · Fair price | ||
 Steris | 31.8× · Expensive | ||
 Zimmer Biomet Holdings | 28.8× · Fair price |
AI analysis
An AI analyst reads Nexalin Technology's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 1 | 0 | 0 | 0 | |
| 1 | 0 | 0 | 0 | |
| -2 | -6 | -8 | -8 | |
| -2 | -6 | -8 | -8 | |
| -2 | -5 | -8 | -8 | |
| -0.30 | -0.63 | -0.83 | -0.50 | |
| 72.5% | 76.8% | 78.3% | 79.7% | |
| -138.7% | -5,143.5% | -4,596.1% | -2,781.7% | |
| -128.5% | -4,197.6% | -4,508.7% | -2,725.8% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 7 | 4 | 4 | 5 |
| Cash | 0 | 1 | 1 | 1 |
| Total debt | 1 | 0 | 0 | – |
| Total liabilities | 2 | 0 | 1 | 1 |
| 5 | 3 | 4 | 4 | |
| 6 | 7 | 9 | 16 | |
| -23.2% | -140.1% | -166.7% | -176.9% | |
| -31.0% | -145.0% | -206.9% | -219.4% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -2 | -4 | -4 | -5 | |
| – | 0 | 0 | 0 | |
| -2 | -4 | -4 | -5 | |
| Dividends paid | – | – | – | – |
| – | – | – | – | |
| 0 | 2 | 4 | 3 |
Valuation
- –
- –
- –
- 2.4×
- 6.1×
- –
- –
- -276.6%
- -450.0%
- 0.0%
Profitability
- 79.7%
- -2,781.7%
- -2,725.8%
- -3,038.5%
- -294.5%
- 26.5%
- -191.9%
- -225.5%
- -294.5%
- 371.4%
Growth
- −38.9%
- –
- −25.7%
- –
- +22.5%
Financial health
- -0.1×
- 0.00
- 0.0%
- –
- 4.07
- 3.85
- 0.07
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 2%of 889
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 8, 2026 | -0.11 | -0.10 | −10.0% |
| Mar 25, 2026 | -0.13 | -0.12 | −8.3% |
| Nov 14, 2025 | -0.13 | -0.12 | −8.3% |
| Aug 6, 2025 | -0.10 | -0.10 | +0.0% |
| May 13, 2025 | -0.15 | -0.10 | −50.0% |
| Mar 14, 2025 | -0.28 | -0.12 | −133.3% |
| Nov 8, 2024 | -0.23 | -0.12 | −91.7% |
| Aug 8, 2024 | -0.17 | – | – |
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
3/6Passes 3 of 6. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
56No pass
Benjamin Graham
55No pass
Philip Fisher
65Pass
Peter Lynch
44No pass
Joel Greenblatt
–Not enough data
Charlie Munger
71Pass
Terry Smith
61Pass
Questions about Nexalin Technology
Is Nexalin Technology a good stock to buy?
A business with weak numbers that is not profitable yet. 3 of the 6 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Nexalin Technology AI analysis
What does Nexalin Technology do?
Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. It is in Medical - Devices.
Does Nexalin Technology pay a dividend?
No. Nexalin Technology does not pay a dividend at the moment.
Is Nexalin Technology stock halal?
No. Nexalin Technology does not pass our halal screen: its cash and confirmed interest-bearing investments are 36% of its market value, at or above the 33% limit. How we check
How has Nexalin Technology stock done over the past year?
Down 95.7% over the past twelve months, to $1.59. It traded between $1.40 and $37.80 and is 95.8% below its high.
Who are Nexalin Technology's competitors?
The largest listed companies in the same industry are Boston Scientific, Koninklijke Philips, Steris and Zimmer Biomet Holdings. The peers table on this page compares their profit, growth and price with Nexalin Technology's.
Prices: daily closes to Nov 11, 2026. Fundamentals: company reports via invest-like data.